As for CRPC, hormonal therapy is not effective for the less frequent type of PCa, small-cell neuroendocrine carcinoma (SCNC), which paradoxically is negative for AR and PSA expression [4]. This evidence concerns the gene KLK3 and posterior cortical atrophy.